Literature DB >> 28569398

Sodium MRI of T1 High Signal Intensity in the Dentate Nucleus due to Gadolinium Deposition in Multiple Sclerosis.

Philipp Eisele1, Simon Konstandin2,3, Kristina Szabo1, Melissa Ong4, Frank Zöllner3, Lothar R Schad3, Stefan O Schoenberg4, Achim Gass1.   

Abstract

BACKGROUND AND
PURPOSE: Recently, several studies reported increased signal intensity (SI) of the dentate nucleus (DN) on unenhanced T1-weighted magnetic resonance imaging (MRI) as a possible consequence of multiple applications of gadolinium-based contrast agents. The aim of this study was to investigate with sodium (23 Na) MRI possible tissue abnormalities of the DN in multiple sclerosis (MS) patients.
METHODS: Sodium and conventional MRI were performed on a clinical 3T scanner. Total sodium concentrations (TSCs) of the DN, as well as DN-to-pons and DN-to-cerebellum SI ratios on unenhanced T1-weighted MRI were calculated.
RESULTS: A total of 18 subjects (6/18 normal controls, 12/18 MS patients [6/12 with T1 hyperintense DN]) were investigated. There was no significant difference of TSC values of the DN in MS patients with a T1-hyperintense DN (33.70 ± 2.14 mM) compared to MS patients without those signal abnormalities (33.29 ± 1.67 mM; P = .67) or to healthy controls (33.14 ± 1.12; P = .32).
CONCLUSIONS: Normal sodium signal in the T1-hyperintense DN in MS patients may point to relative tissue integrity despite gadolinium deposition in this area.
Copyright © 2017 by the American Society of Neuroimaging.

Entities:  

Keywords:  23Na; MRI; Multiple sclerosis; dentate nucleus; gadolinium; sodium

Mesh:

Substances:

Year:  2017        PMID: 28569398     DOI: 10.1111/jon.12448

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  9 in total

Review 1.  Clinical applications of ultra-high field magnetic resonance imaging in multiple sclerosis.

Authors:  Matilde Inglese; Lazar Fleysher; Niels Oesingmann; Maria Petracca
Journal:  Expert Rev Neurother       Date:  2018-01-30       Impact factor: 4.618

Review 2.  Standardized assessment of the signal intensity increase on unenhanced T1-weighted images in the brain: the European Gadolinium Retention Evaluation Consortium (GREC) Task Force position statement.

Authors:  Carlo C Quattrocchi; Joana Ramalho; Aart J van der Molen; Àlex Rovira; Alexander Radbruch
Journal:  Eur Radiol       Date:  2018-11-09       Impact factor: 5.315

3.  Gadolinium Deposition Safety: Seeking the Patient's Perspective.

Authors:  C A Mallio; C C Quattrocchi; À Rovira; P M Parizel
Journal:  AJNR Am J Neuroradiol       Date:  2020-05-07       Impact factor: 3.825

4.  Cumulative gadodiamide administration leads to brain gadolinium deposition in early MS.

Authors:  Robert Zivadinov; Niels Bergsland; Jesper Hagemeier; Deepa P Ramasamy; Michael G Dwyer; Ferdinand Schweser; Channa Kolb; Bianca Weinstock-Guttman; David Hojnacki
Journal:  Neurology       Date:  2019-07-08       Impact factor: 11.800

5.  Visible T1-hyperintensity of the dentate nucleus after multiple administrations of macrocyclic gadolinium-based contrast agents: yes or no?

Authors:  Alessandra Splendiani; Antonella Corridore; Silvia Torlone; Milvia Martino; Antonio Barile; Ernesto Di Cesare; Carlo Masciocchi
Journal:  Insights Imaging       Date:  2019-09-04

6.  Gadolinium deposition in the brain of dogs after multiple intravenous administrations of linear gadolinium based contrast agents.

Authors:  Henning Richter; Patrick Bücker; Calvin Dunker; Uwe Karst; Patrick Robert Kircher
Journal:  PLoS One       Date:  2020-02-03       Impact factor: 3.240

7.  Prospective Multicenter Study of the Safety of Gadoteridol in 6163 Patients.

Authors:  Sung Bum Cho; A-Leum Lee; Hyuk Won Chang; Kyeong Ah Kim; Won Jong Yoo; Jeong A Yeom; Myung Ho Rho; Sung Jin Kim; Yun-Jung Lim; Miran Han
Journal:  J Magn Reson Imaging       Date:  2019-10-29       Impact factor: 4.813

8.  Anterior pituitary gland T1 signal intensity is influenced by time delay after injection of gadodiamide.

Authors:  Carlo A Mallio; Laura Messina; Marco Parillo; Gianguido Lo Vullo; Bruno Beomonte Zobel; Paul M Parizel; Carlo C Quattrocchi
Journal:  Sci Rep       Date:  2020-09-11       Impact factor: 4.379

9.  Sodium Intensity Changes Differ Between Relaxation- and Density-Weighted MRI in Multiple Sclerosis.

Authors:  Robert Stobbe; Annie Boyd; Penelope Smyth; Derek Emery; Diana Valdés Cabrera; Christian Beaulieu
Journal:  Front Neurol       Date:  2021-07-14       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.